China SXT Pharmaceuticals, Inc. (SXTC)
NASDAQ: SXTC · IEX Real-Time Price · USD
-0.060 (-4.05%)
At close: Apr 12, 2024, 3:40 PM
+0.020 (1.41%)
After-hours: Apr 12, 2024, 5:58 PM EDT

China SXT Pharmaceuticals Statistics

Total Valuation

SXTC has a market cap or net worth of $14.62 million. The enterprise value is $6.83 million.

Market Cap 14.62M
Enterprise Value 6.83M

Important Dates

The last earnings date was Monday, August 19, 2019, before market open.

Earnings Date Aug 19, 2019
Ex-Dividend Date n/a

Share Statistics

SXTC has 10.45 million shares outstanding.

Shares Outstanding 10.45M
Owned by Insiders (%) 22.01%
Owned by Institutions (%) 1.62%
Float n/a

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 506.27
Forward PS n/a
PB Ratio 2.98
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 228.38
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.47, with a Debt / Equity ratio of 0.62.

Current Ratio 1.47
Quick Ratio 1.40
Debt / Equity 0.62
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -31.95

Financial Efficiency

Return on equity (ROE) is -141.60% and return on invested capital (ROIC) is -161.94%.

Return on Equity (ROE) -141.60%
Return on Assets (ROA) -76.90%
Return on Capital (ROIC) -161.94%
Revenue Per Employee $384
Profits Per Employee -$181,235
Employee Count 78
Asset Turnover 0.00
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -74.59% in the last 52 weeks. The beta is 1.02, so SXTC's price volatility has been similar to the market average.

Beta (1Y) 1.02
52-Week Price Change -74.59%
50-Day Moving Average 1.86
200-Day Moving Average 2.82
Relative Strength Index (RSI) 35.12
Average Volume (30 Days) 626,740

Short Selling Information

Short Interest 26,244
Short Previous Month 5,539
Short % of Shares Out 1.30%
Short % of Float n/a
Short Ratio (days to cover) 0.02

Income Statement

In the last 12 months, SXTC had revenue of $29,919 and -$14.14 million in losses. Loss per share was -$26.97.

Revenue 29,919
Gross Profit 1.11M
Operating Income -13.32M
Pretax Income -14.14M
Net Income -14.14M
EBITDA -13.36M
EBIT -13.71M
Loss Per Share -$26.97
Full Income Statement

Balance Sheet

The company has $11.47 million in cash and $3.15 million in debt, giving a net cash position of $8.31 million or $0.80 per share.

Cash & Cash Equivalents 11.47M
Total Debt 3.15M
Net Cash 8.31M
Net Cash Per Share $0.80
Equity / Book Value 5.08M
Book Value Per Share 0.49
Working Capital 4.30M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$111,200 and capital expenditures -$50,569, giving a free cash flow of -$161,769.

Operating Cash Flow -111,200
Capital Expenditures -50,569
Free Cash Flow -161,769
FCF Per Share -$0.32
Full Cash Flow Statement


Gross margin is 3,703.22%, with operating and profit margins of -44,530.39% and -47,248.64%.

Gross Margin 3,703.22%
Operating Margin -44,530.39%
Pretax Margin -47,248.64%
Profit Margin -47,248.64%
EBITDA Margin -44,641.31%
EBIT Margin -45,814.74%
FCF Margin -540.69%

Dividends & Yields

SXTC does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -1,512.49%
Shareholder Yield -1,512.49%
Earnings Yield -93.33%
FCF Yield -1.07%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Stock Splits

The last stock split was on October 5, 2023. It was a reverse split with a ratio of 1:25.

Last Split Date Oct 5, 2023
Split Type Reverse
Split Ratio 1:25


SXTC has an Altman Z-Score of -4.79 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -4.79
Piotroski F-Score 4